PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
CCL7 274 Target Target CXCL10 2,386 51 0.06 -0.89 0.19 0.77
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
CXCL7 76 Target Target CCL5 2,002 14 0.04 -0.90 0.18 0.74
Obesity 138,233 Disease Target ADSF 11 2 0.00 -0.90 0.18 0.59
ELC 355 Target Target DC-CK1 22 4 0.05 -0.90 0.18 0.77
Breast Cancer 173,695 Disease Target Multidrug Resistance Protein 1 495 90 0.01 -0.90 0.18 0.62
CNTF 1,613 Target Target BDNF 11,163 292 0.07 -0.89 0.18 0.75
Cholesterol 182,390 Disease Target Bile Salt Export Pump 476 86 0.01 -0.90 0.18 0.62
Schizophrenia 77,034 Disease Target Metabotropic Glutamate Receptor 2 72 13 0.01 -0.91 0.18 0.62
Cancer 1,053,491 Disease Target AFP 9,751 1,749 0.02 -0.91 0.18 0.59
CCL3 1,427 Target Target CCL1 220 39 0.07 -0.89 0.18 0.78
CCL5 2,002 Target Target CXCL9 1,016 180 0.13 -0.87 0.18 0.83
CD4 112,219 Target Target CD72 198 35 0.01 -0.91 0.18 0.62
Lung Cancer 91,416 Disease Target beta-Cellulin 17 3 0.00 -0.91 0.18 0.60
Non Small Cell Lung Cancer 28,563 Disease Target beta-Cellulin 17 3 0.00 -0.91 0.18 0.63
Glucocorticoid Receptor 10,306 Target Target Vitamin D Receptor Interacting Protein 17 3 0.01 -0.91 0.18 0.66
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
Carcinoma 433,099 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.57
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Erbb2 4,536 Target Target beta-Cellulin 17 3 0.01 -0.91 0.18 0.68
CCL5 2,002 Target Target CCL14 34 6 0.02 -0.91 0.18 0.72
CCL14 34 Target Target CXCL10 2,386 6 0.02 -0.91 0.18 0.71
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
ERBB4 994 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.73
Breast Cancer 173,695 Disease Target beta-Cellulin 17 3 0.00 -0.91 0.18 0.59
Asthma 109,610 Disease Target Crth2 Receptor 51 9 0.00 -0.91 0.18 0.61
ERBB3 1,154 Target Target beta-Cellulin 17 3 0.02 -0.91 0.18 0.72
Lung Cancer 91,416 Disease Target beta-Cellulin 17 3 0.00 -0.91 0.18 0.60
Carcinoma 433,099 Disease Target DAPK1 205 36 0.00 -0.91 0.18 0.58
Carcinoma 433,099 Disease Target Erbb2 4,536 793 0.02 -0.91 0.17 0.61
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Breast Cancer 173,695 Disease Target ERBB3 1,154 198 0.01 -0.91 0.17 0.63
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cholesterol 182,390 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.60
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
CXCL7 76 Target Target CXCL2 750 13 0.05 -0.90 0.17 0.78
Cancer 1,053,491 Disease Target ETS1 539 92 0.00 -0.91 0.17 0.56
Epidermal Growth Factor Receptor 24,772 Target Target Erbb2 4,536 770 0.07 -0.90 0.17 0.74
Collagen 138,882 Target Target Complement Component C1q 167 28 0.01 -0.91 0.17 0.61
Carcinoma 433,099 Disease Target EPHA2 532 89 0.01 -0.91 0.17 0.59
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80